News
News

The latest updates from AFAR.

Board and Grantees in the News: Geroscience Network publishes strategies for moving drugs into clinical trials

Aug 26
2016

Board and Grantees in the News: Geroscience Network publishes strategies for moving drugs into clinical trials

Recently, the Geroscience Network, led by AFAR board members, Steven Austad, PhD (Scientific Director), Nir Barzilai, MD (Deputy Scientific Director), and James Kirkland, MD, PhD, published six manuscripts that map strategies for moving new drugs that target processes underlying aging into clinical trials. These AFAR experts believe that these agents hold promise for treating multiple age-related diseases and disabilities.  Read the complete manuscripts in the Journal of Gerontology Series A - Biological Sciences and Medical Sciences. Manuscript topics include: • "Barriers to the Preclinical Development of Therapeutics That Target Aging Mechanisms" • "Frameworks for Proof-of-Concept Clinical Trials of Interventions…


View MoreREAD MORE


Board Member in the News: Scientific Director Steven Austad on Bio-markers of Aging in Hispanic study

Aug 23
2016

Board Member in the News: Scientific Director Steven Austad on Bio-markers of Aging in Hispanic study

On August 19th, 2016, HealthDay, reported on new research indicating that Hispanics may age slower than other demographic groups.  AFAR Scientific Director Steven Austad, PhD, commented on the research methods used in this study and possible wider application within the field of aging research. Based on existing research pointing to longer average life expectancy for Hispanics, researchers developed a biological clock which evaluates the rate of DNA methylation occurring in a person's blood and other tissues, and found that Hispanics aged more slowly the seven other ethnic groups tested. Dr. Austad believes that once confirmed accurate, the biological clock…


View MoreREAD MORE


Grantee in the News: Mike Henne on New Research Linking Weight to Brain Mass

Aug 17
2016

Grantee in the News: Mike Henne on New Research Linking Weight to Brain Mass

On August 9th, WebMD featured commentary from 2015 AFAR Research Grant recipient, Mike Henne, PhD, on the implications of new research showing a correlation between being overweight or obese in middle age and dramatically reduced white matter in the brain. Research coming out the UK found that being overweight or obese in middle age shrinks your brain, aging it by as much as 10 years.  According to Dr. Henne, ''The white matter of the brain is thought to be the first to go with dementia."  While, the new study did not link being overweight with an earlier onset of…


View MoreREAD MORE


Grantees in the News: US News and World Reports Feature spotlights AFAR experts on the Future of Aging Research

Aug 10
2016

Grantees in the News: US News and World Reports Feature spotlights AFAR experts on the Future of Aging Research

On August 9th, 2016, US News and World Reports featured AFAR board members, Steven Austad, PhD (Scientific Director); Nir Barzilai, MD (Deputy Scientific Director); James Kirkland, MD, PhD; as well as grantees Brian Kennedy (2003 AFAR Research Grant, 2008 Mid-Career Award); Thomas Perls, MD (1998 Beeson Scholar); Felipe Sierra, PhD (1993 AFAR Research Grant); Ana Maria Cuervo (2000 AFAR Research Grant); Valter Longo, PhD (1998 AFAR Research Grant) and Matt Kaeberlein, PhD (2006 AFAR Research Grant, 2007 BIG Award) in a comprehensive piece on the future of aging research. The article provides an overarching summary of geoscience, the field which explores the relationship between aging and diseases like…


View MoreREAD MORE


Grantee in the News: Nir Barzilai and Judith Campisi on promising research projects in The Toronto Star

Aug 10
2016

Grantee in the News: Nir Barzilai and Judith Campisi on promising research projects in The Toronto Star

On August 7th, 2016, two-time grantee and Deputy Scientific Director, Nir Barzilai, MD, and 1990 AFAR Research Grant recipient, Judith Campisi, PhD, were featured in The Toronto Star’s round up for promising projects in the aging research. In an article titled “The Search for the ‘Holy Grail’ of Aging Research,” The Star noted exciting advancements in aging research including promising studies looking at rapamycin and metformin as potential intervention for targeting aging.  As Drs. Campisi and Barzilai pointed out, the main goal of these projects in better health, not life extension. &ldquo…


View MoreREAD MORE




BACK TO TOPBACK TO TOP